Update: 30.07.2024
Last week: 28 week 2024 (15.07.2024 - 21.07.2024)
Last full month: June 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 785 | -6.0% | 13.4% | -0.4 | 14 881 448 | -6.9% | 9.7% | -0.5 | -3.1% |
| MoM | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| YTD | 209 491 | 19.1% | 11.4% | 2.5 | 455 480 957 | 40.9% | 9.4% | 2 | -7.5% |
| MAT | 374 472 | 25.1% | 10.5% | 1.9 | 788 942 671 | 44.0% | 8.8% | 1.5 | 2.1% |
| BRAINMAX | |||||||||
| WoW | 1 061 | -20.9% | 100.0% | 0 | 3 988 430 | -19.9% | 100.0% | 0 | -20.9% |
| MoM | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| YTD | 30 538 | 40.0% | 100.0% | 0 | 111 503 142 | 52.0% | 100.0% | 0 | 40.0% |
| MAT | 55 376 | 73.4% | 100.0% | 0 | 199 145 987 | 88.1% | 100.0% | 0 | 73.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 349 | -3.0% | 46.1% | -0.1 | 47 730 427 | -3.7% | 38.1% | 0 | -2.9% |
| MoM | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| YTD | 496 067 | -3.5% | 44.9% | 1 | 1 564 588 864 | -0.0% | 36.6% | -2.7 | -5.6% |
| MAT | 851 133 | 5.3% | 45.5% | 1.1 | 2 691 592 300 | 11.9% | 38.0% | -1.4 | 2.8% |
| MIGRENIUM | |||||||||
| WoW | 10 325 | -2.8% | 0.5% | 0 | 3 467 043 | -2.9% | 0.6% | 0 | 0.9% |
| MoM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| YTD | 343 133 | -4.5% | 0.5% | -0.1 | 105 341 535 | 61.9% | 0.7% | 0.2 | 10.6% |
| MAT | 625 531 | -2.5% | 0.5% | -0.1 | 162 936 377 | 39.8% | 0.6% | 0.1 | 14.3% |
| MODELAX-N | |||||||||
| WoW | 23 309 | -3.7% | 19.0% | -1.1 | 10 825 182 | -4.4% | 12.8% | -0.7 | 1.9% |
| MoM | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| YTD | 866 609 | 38.2% | 23.3% | 4.6 | 370 439 804 | 87.9% | 15.0% | 4.5 | 11.1% |
| MAT | 1 407 309 | 64.4% | 21.2% | 5.9 | 556 122 121 | 102.6% | 12.9% | 4.3 | 18.5% |
| REDUXIN | |||||||||
| WoW | 11 093 | -1.5% | 33.3% | 0.5 | 56 175 413 | -3.1% | 44.9% | 0.3 | -2.9% |
| MoM | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| YTD | 364 115 | -8.3% | 32.9% | -1 | 1 956 927 161 | 15.9% | 45.8% | 3.4 | -5.6% |
| MAT | 604 684 | -2.9% | 32.3% | -1.9 | 3 141 918 457 | 20.5% | 44.4% | 1.6 | 2.8% |
| REDUXIN FORTE | |||||||||
| WoW | 3 063 | -5.2% | 9.2% | -0.2 | 12 886 657 | -6.5% | 10.3% | -0.3 | -2.9% |
| MoM | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| YTD | 96 988 | 0.9% | 8.8% | 0.6 | 420 930 196 | 15.7% | 9.9% | 0.7 | -5.6% |
| MAT | 166 918 | 14.3% | 8.9% | 0.9 | 710 499 046 | 27.5% | 10.0% | 0.9 | 2.8% |
| SALVISAR | |||||||||
| WoW | 8 021 | 4.0% | 1.1% | 0 | 3 590 944 | 2.6% | 1.1% | 0 | 0.3% |
| MoM | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
| YTD | 295 243 | 1.8% | 1.4% | 0 | 119 412 591 | 26.9% | 1.2% | 0.1 | -0.6% |
| MAT | 503 613 | -12.2% | 1.3% | -0.2 | 189 084 192 | -2.0% | 1.1% | -0.2 | 4.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 209 491 | 19.1% | 11.4% | 2.5 | 455 480 957 | 40.9% | 9.4% | 2 | -7.5% |
| BRAINMAX | 30 538 | 40.0% | 100.0% | 0 | 111 503 142 | 52.0% | 100.0% | 0 | 40.0% |
| GOLDLINE PLUS | 496 067 | -3.5% | 44.9% | 1 | 1 564 588 864 | -0.0% | 36.6% | -2.7 | -5.6% |
| MIGRENIUM | 343 133 | -4.5% | 0.5% | -0.1 | 105 341 535 | 61.9% | 0.7% | 0.2 | 10.6% |
| MODELAX-N | 866 609 | 38.2% | 23.3% | 4.6 | 370 439 804 | 87.9% | 15.0% | 4.5 | 11.1% |
| REDUXIN CAPS | 364 115 | -8.3% | 32.9% | -1 | 1 956 927 161 | 15.9% | 45.8% | 3.4 | -5.6% |
| REDUXIN FORTE | 96 988 | 0.9% | 8.8% | 0.6 | 420 930 196 | 15.7% | 9.9% | 0.7 | -5.6% |
| SALVISAR | 295 243 | 1.8% | 1.4% | 0 | 119 412 591 | 26.9% | 1.2% | 0.1 | -0.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 374 472 | 25.1% | 10.5% | 1.9 | 788 942 671 | 44.0% | 8.8% | 1.5 | 2.1% |
| BRAINMAX | 55 376 | 73.4% | 100.0% | 0 | 199 145 987 | 88.1% | 100.0% | 0 | 73.4% |
| GOLDLINE PLUS | 851 133 | 5.3% | 45.5% | 1.1 | 2 691 592 300 | 11.9% | 38.0% | -1.4 | 2.8% |
| MIGRENIUM | 625 531 | -2.5% | 0.5% | -0.1 | 162 936 377 | 39.8% | 0.6% | 0.1 | 14.3% |
| MODELAX-N | 1 407 309 | 64.4% | 21.2% | 5.9 | 556 122 121 | 102.6% | 12.9% | 4.3 | 18.5% |
| REDUXIN CAPS | 604 684 | -2.9% | 32.3% | -1.9 | 3 141 918 457 | 20.5% | 44.4% | 1.6 | 2.8% |
| REDUXIN FORTE | 166 918 | 14.3% | 8.9% | 0.9 | 710 499 046 | 27.5% | 10.0% | 0.9 | 2.8% |
| SALVISAR | 503 613 | -12.2% | 1.3% | -0.2 | 189 084 192 | -2.0% | 1.1% | -0.2 | 4.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 785 | -6.0% | 13.4% | -0.4 | 14 881 448 | -6.9% | 9.7% | -0.5 | -3.1% |
| BRAINMAX | 1 061 | -20.9% | 100.0% | 0 | 3 988 430 | -19.9% | 100.0% | 0 | -20.9% |
| GOLDLINE PLUS | 15 349 | -3.0% | 46.1% | -0.1 | 47 730 427 | -3.7% | 38.1% | 0 | -2.9% |
| MIGRENIUM | 10 325 | -2.8% | 0.5% | 0 | 3 467 043 | -2.9% | 0.6% | 0 | 0.9% |
| MODELAX-N | 23 309 | -3.7% | 19.0% | -1.1 | 10 825 182 | -4.4% | 12.8% | -0.7 | 1.9% |
| REDUXIN CAPS | 11 093 | -1.5% | 33.3% | 0.5 | 56 175 413 | -3.1% | 44.9% | 0.3 | -2.9% |
| REDUXIN FORTE | 3 063 | -5.2% | 9.2% | -0.2 | 12 886 657 | -6.5% | 10.3% | -0.3 | -2.9% |
| SALVISAR | 8 021 | 4.0% | 1.1% | 0 | 3 590 944 | 2.6% | 1.1% | 0 | 0.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| BRAINMAX | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| GOLDLINE PLUS | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| MIGRENIUM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| MODELAX-N | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| REDUXIN CAPS | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| REDUXIN FORTE | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| SALVISAR | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs